Farther Finance Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Buy |
8,160
+7,651
| +1,503% | +$183K | ﹤0.01% | 1398 |
|
|
2025
Q1 | $12.3K | Buy |
+509
| New | +$12.3K | ﹤0.01% | 2641 |
|
|
2024
Q4 | – | Sell |
-8
| Closed | -$120 | – | 4111 |
|
|
2024
Q3 | $120 | Sell |
8
-22
| -73% | -$330 | ﹤0.01% | 3743 |
|
|
2024
Q2 | $854 | Buy |
30
+26
| +650% | +$740 | ﹤0.01% | 3122 |
|
|
2024
Q1 | $117 | Sell |
4
-38
| -90% | -$1.11K | ﹤0.01% | 3354 |
|
|
2023
Q4 | $1.42K | Buy |
42
+37
| +740% | +$1.25K | ﹤0.01% | 2579 |
|
|
2023
Q3 | $153 | Buy |
+5
| New | +$153 | ﹤0.01% | 2504 |
|
|
2023
Q2 | – | Sell |
-15
| Closed | -$612 | – | 2546 |
|
|
2023
Q1 | $612 | Buy |
+15
| New | +$612 | ﹤0.01% | 1955 |
|